Elevated Melatonin Levels Found in Young Myopic Adults Are Not Attributable to a Shift in Circadian Phase by Flanagan, Sarah et al.
Physiology and Pharmacology
Elevated Melatonin Levels Found in Young Myopic Adults
Are Not Attributable to a Shift in Circadian Phase
Sarah C. Flanagan ,1 Diego Cobice,2 Patrick Richardson,1 Julie J. Sittlington,3
and Kathryn J. Saunders 1
1Centre for Optometry and Vision Science, Biomedical Science Research Institute, Ulster University, Coleraine, Northern
Ireland
2Mass Spectrometry Centre, Biomedical Science Research Institute, Ulster University, Coleraine, Northern Ireland
3Nutrition Innovation Centre for Food and Health (NICHE), Biomedical Science Research Institute, Ulster University,
Coleraine, Northern Ireland
Correspondence: Sarah C. Flanagan,
Optometry and Vision Sciences,
Ulster University, Cromore Road,
Coleraine Co. Londonderry, BT52
1SA, NIR;
flanagan-s6@ulster.ac.uk.
Received: March 31, 2020
Accepted: June 17, 2020
Published: July 30, 2020
Citation: Flanagan SC, Cobice D,
Richardson P, Sittlington JJ,
Saunders KJ. Elevated melatonin
levels found in young myopic adults
are not attributable to a shift in
circadian phase. Invest Ophthalmol
Vis Sci. 2020;61(8):45.
https://doi.org/10.1167/iovs.61.8.45
PURPOSE. To evaluate the relationship between refractive error, circadian phase, and mela-
tonin with consideration of prior light exposure, physical activity, and sleep.
METHODS. Healthy young myopic (spherical equivalent refraction [SER] ≤−0.50DS)
and emmetropic adults underwent noncycloplegic autorefraction and axial length (AL)
measures. Objective measurements of light exposure, physical activity, and sleep were
captured across 7 days by wrist-worn Actiwatch-2 devices. Questionnaires assessed sleep
quality and chronotype. Hourly evening saliva sampling during a dim-light melatonin
onset (DLMO) protocol evaluated circadian phase, and both morning serum and saliva
samples were collected. Liquid chromatography/mass spectrometry quantified melatonin.
RESULTS. Subjects (n = 51) were aged 21.4 (interquartile range, 20.1−24.0) years. Mela-
tonin was significantly higher in the myopic group at every evening time point and
with both morning serum and saliva sampling (P ≤ 0.001 for all). DLMO-derived circa-
dian phase did not differ between groups (P = 0.98). Multiple linear regression analysis
demonstrated significant associations between serum melatonin and SER (B = –.34, β =
–.42, P = 0.001), moderate activity (B = .009, β = .32, P = 0.01), and mesopic illumi-
nation (B = –.007, β = –.29, P = 0.02), F(3, 46) = 7.23, P < 0.001, R2 = 0.32, R2adjusted
= .28. Myopes spent significantly more time exposed to “indoor” photopic illumination
(3 to ≤1000 lux; P = 0.05), but “indoor” photopic illumination was not associated with
SER, AL, or melatonin, and neither sleep, physical activity, nor any other light exposure
metric differed significantly between groups (P > 0.05 for all).
CONCLUSIONS. While circadian phase is aligned in adult myopes and emmetropes, myopia
is associated with both elevated serum and salivary melatonin levels. Prospective studies
are required to ascertain whether elevated melatonin levels occur before, during, or after
myopia development.
Keywords: circadian rhythm, circadian phase, DLMO (dim-light melatonin onset), mela-
tonin, myopia, refractive error, light exposure, physical activity
During childhood, visual experience guides homeo-static eye growth. This complex regulatory process
aims to achieve a fine balance between the eye’s axial
length and optical power so that light is focused directly
on the retina. Failure of this process leads to refractive
error, including myopia, a progressive condition typically
caused by excessive eye growth and characterized by blurred
distance vision.1 In addition to causing blurred distance
vision, increasing levels of myopia are associated with an
increased lifetime risk of sight-threatening ocular pathol-
ogy.2 It is therefore of concern that myopia is predicted
to affect almost 50% of the global population by the year
2050.3
Both genetic and environmental factors contribute to
myopia development; however, the exact pathophysiology is
unclear. It is thought that exposure to modern urban envi-
ronments, prioritizing education and providing less oppor-
tunity for spending time outdoors, plays a major role in
the recent surge of myopia.4,5 Observational studies and
randomized controlled trials have established that spending
more time outdoors protects against myopia onset.6–14 This
finding has been used to develop antimyopia public health
policies in countries with high myopia prevalence.15–17
However, the precise protective elements by which the
outdoor environment shields against myopia are unclear.18
This is problematic, especially in countries where ultraviolet
(UV) radiation is high. Advising children to spend more time
outdoors may be counterintuitive to decades of public health
campaigning aimed at preventing UV-related skin damage
and pathology. Therefore, defining the beneficial aspects
of the outdoor environment and exploring the potential
biological pathways by which time outdoors protects against
myopia are urgently required to refine global public health
guidelines.
Copyright 2020 The Authors
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Spending more time outdoors reduces opportunity for
near work and a sedentary lifestyle, both observed risk
factors for myopia.19,20 However, as time spent outdoors
has been found to independently predict myopia incidence7
and remains protective against myopia development after
controlling for near work and physical activity,21 it is unlikely
that these factors are crucial protective aspects of time
outdoors. Potential protective features of the outdoor envi-
ronment include a greater illuminance and broader spectrum
of light, a higher spatial frequency content of visual input,
and reduced opportunity for the peripheral retina to receive
growth-promoting defocus signals.2,22 The mechanisms by
which these features may act, alone or in combination, to
regulate homeostatic eye growth also remain unclear.
Increasing evidence implicates circadian rhythms in
refractive error development (see Chakraborty et al.23 for
a comprehensive review). Supportive of the hypotheses
presented by Chakraborty et al.,23 recent work demonstrates
that knockout of the circadian gene Bmal1 in the mouse
retina or the circadian genes cycle and period in Drosophila
melanogaster both result in myopic phenotypes,24 and find-
ings from a recent meta-analysis of genome-wide associa-
tion studies suggest that genetic factors that control circa-
dian rhythms are involved in human myopia development.25
Circadian rhythms are biological processes that display
an endogenous, entrainable oscillation of approximately 24
hours. In humans, these rhythms form a hierarchy of oscil-
lators, orchestrated by a central pacemaker located in the
suprachiasmatic nuclei (SCN), to synchronize our physiol-
ogy and behaviors to the changing demands of the day-
night cycle.26 In addition to internal regulation by the central
pacemaker, temporal information can be elicited from vari-
ous external cues, including light exposure, physical activ-
ity, mealtimes, and social interactions. Rhythmic changes in
the light-dark cycle and alterations thereof provide the most
potent zeitgeber to our circadian system.27,28
When light stimulates the retina, photoreceptor signals
are integrated through short-wavelength-sensitive intrinsi-
cally photosensitive retinal ganglion cells to initiate the
release of dopamine from amacrine cells and the inhibition
of melatonin synthesis in the pineal gland. Dopamine and
melatonin are mutually inhibitory hormones that oscillate in
antiphase with circadian rhythmicity, helping to coordinate
the circadian system.29 Typically, dopamine synthesis peaks
during daylight hours and melatonin secretion peaks at
night. The secretion of these hormones can be influenced by
altering environmental light exposure patterns, encouraging
or suppressing secretion earlier or later in the 24-hour cycle.
For example, greater levels of light exposure in the morning
advance melatonin secretion, and conversely, if more light is
delivered in the evening, a common phenomenon in modern
life, melatonin secretion is delayed.30,31
A role for dopamine in eye growth signaling has
been strongly implicated by previous research,23,32,33 and
dopamine is proposed to mediate the protective effects of
increased time outdoors against myopia by regulating circa-
dian physiology.23,34 Circadian rhythms are known to exist
within the eye,35,36 and various ocular parameters have been
seen to demonstrate diurnal oscillation.37–39 Briefly, greater
levels of dopamine appear protective against experimental
myopia. In the chick eye, daytime levels of retinal dopamine
and its principal metabolite, 3,4-dihydroxyphenylacetic acid,
have been shown to reduce in response to form depriva-
tion40,41 or lens-induced myopia42 and to recover to original
levels 1 week following the removal of form deprivation.41
Moreover, application of a dopamine agonist, apomor-
phine, by eye drop or subconjunctival injection increases
retinal dopamine and mitigates against form deprivation
myopia40,43,44 and lens-induced myopia in various animal
models.45,46 Dopamine is known to contribute to the regula-
tion of ocular rhythms35,36 and is upregulated in both retinal
and neural tissue when light is detected by the retina.47,48
Furthermore, intravitreal injection of a dopamine antago-
nist, spiperone, abolishes the protective effect of bright light
against form deprivation myopia.49
Due to the challenges associated with quantifying reti-
nal dopamine in humans, research exploring dopaminer-
gic pathways and myopia has been mostly restricted to
animal models. One refractive error study evaluated circu-
lating dopamine levels in young adults and reported signif-
icantly lower serum levels in adult myopes compared with
nonmyopes at the end of winter but not summer.50 However,
due to dopamine’s complex synthesis by both the central
nervous system and peripheral organs, as well as its inabil-
ity to cross the blood-brain barrier, it is unclear whether
measuring circulating dopamine in isolation of its metabo-
lites is appropriate and whether results can be extrapolated
to usefully indicate retinal dopamine levels in the context of
refractive error studies.51
For these reasons, studies evaluating the relation-
ship between human myopia and circadian rhythms
have assessed the circadian hormone melatonin, a well-
documented robust biomarker of internal circadian phase.52
Due to melatonin’s short half-life, the 24-hour oscillation
of circulating melatonin measured under constant routine
conditions accurately reflects the oscillation of the endoge-
nous pacemaker. However, frequent sampling of circu-
lating melatonin is invasive, time-consuming, and expen-
sive. Consequently, alternative biomarkers that require less
sampling, such as the dim-light melatonin onset (DLMO),
have been developed to assess circadian phase.53,54
In 2017, Kearney et al.50 reported a significant associa-
tion between human refractive error, axial length, and morn-
ing serum melatonin; circulating melatonin was almost three
times higher in myopes compared with nonmyopes. Mela-
tonin has a dynamic circadian secretion profile, and Kearney
et al. sampled melatonin from a single point in this cycle.
As such, the authors were not able to ascertain whether the
difference in melatonin between the myopic and nonmyopic
group was reflective of a phase shift in melatonin’s secre-
tion and/or a higher concentration in circulating melatonin
sustained across all or part of the 24-hour cycle.
The present cross-sectional study builds on Kearney et
al.50 by further exploring differences between melatonin
concentrations in young adults with and without myopia.
In particular, investigating whether circadian phase (iden-
tified by DLMO) differs between myopes and emmetropes
and whether saliva samples obtained through noninvasive
methods elicit interrefractive group differences in melatonin
concentration comparable to those seen in serum. Further-
more, participants’ prior light exposure, physical activity,
and sleep were considered in the present evaluation of mela-
tonin and refractive error.
METHODS
The study was approved by the Ulster University Research
Ethics Committee (REC/18/0089) and adhered to the tenets
of the Declaration of Helsinki, and subjects provided writ-
ten informed consent prior to participation. Recruitment
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and data collection occurred over 8 weeks at the end of
winter (February to March 2019) prior to the onset of
daylight saving time (DST, March 31, 2019). Daylength for
each subject’s participation period was recorded from an
online database (www.timeanddate.com), and these data
were considered during data analysis. Consented subjects
were requested to attend three study appointments at Ulster
University’s Coleraine campus (55°N).
Subjects were aged 18 to 30 years and had not previously
taken part in studies of refractive error and melatonin in
our laboratory (Kearney et al.). Participant age was limited
as melatonin concentration is known to reduce with age.55
Individuals were excluded if they were taking prescribed
medication (e.g., melatonin supplements) or diagnosed with
a medical condition known to affect systemic melatonin
concentration, were a regular smoker (including the use of
a nicotine vaporizer), were pregnant, were breastfeeding,
had irregular menstrual cycles, currently were undergoing
myopia intervention, were diagnosed with ocular disease,
had experienced previous ocular surgery, had completed
regular nightshift work within the past year, had traveled
across more than one time zone in the past month, had a
physical disability that would prevent them from complet-
ing the protocol, or demonstrated a noncycloplegic hyper-
opic autorefraction greater than +2.00 DS.
Visit 1
A brief ocular and clinical history was taken from each
subject to confirm eligibility. Parental history of myopia
was established through a validated questionnaire,56 and
any prescribed or nonprescribed medication and supple-
ments were noted. The impact of menstrual cycle on mela-
tonin status is unclear.57 For this reason, female subjects
were asked to provide the date of the most recent
menstruation to estimate menstrual phase during sample
collection (menstrual phase [from days 1 to 5]; follicu-
lar phase [from days 1 to 13]; ovulation phase [day 14];
luteal phase [from days 15 to 28]). In line with Kear-
ney et al.,50 open-field noncycloplegic autorefraction (SRW-
5000; Shin-Nippon, Tokyo, Japan) was performed bilater-
ally while subjects viewed a distance target. Myopia was
defined as spherical equivalent refraction (SER) ≤−0.50DS
in either eye, and subjects were assigned to the “myopic” or
“emmetropic” group. Axial length (IOLMaster; ZEISS, Carl
Zeiss Meditec AG Jena, Germany) was then measured in the
right eye. To elicit information on sleep quality and chrono-
type (i.e., whether individuals are morning type or evening
type), subjects completed the Pittsburgh Sleep Quality Index
(PSQI)58 and the Horne Ostberg Morningness-Eveningness
Questionnaire (MEQ),59 respectively. Subjects were fitted
with an Actiwatch-2 device (Actiwatch-2; Philips Respironics,
Murrysville, Pennsylvania, United States) on their nondomi-
nant wrist. The Actiwatch-2 is a validated objective method
of measuring sleep/wake patterns and has been used in
numerous myopia-related investigations to quantify light
exposure and physical activity.60–62 The device contains a
solid-state piezoelectric accelerometer with a sampling rate
of 32 Hz to measure physical activity in counts per minute
(CPM) and a silicone photodiode light sensor to measure
photopic illuminance between 5 and 100,000 lux (wave-
length range 400–900 nm; peak sensitivity 570 nm). Subjects
were requested to refrain from removing the device during
the sampling period, except when in water for more than 30
minutes, and were told to keep the light sensor uncovered by
clothing. Devices were programmed to record at 30-second
epochs and dispensed for 7 days.
Visit 2
One week later, subjects returned to the laboratory at
18:45:00 for the dim-light melatonin phase assessment.
Wrist-worn devices were returned to the researcher and data
downloaded. Subjects were requested to eat their evening
meal prior to 18:00:00 and to refrain from alcohol, cigarettes,
nicotine, aspirin, anti-inflammatory-type medications, and
certain foods rich in melatonin (bananas, grapes, cereals,
olives, nuts, etc.) 12 hours prior to the laboratory visit. Room
lights were switched off and residual environmental lighting
was below 30 lux. Screen use was permitted but only at the
lowest brightness intensity and 100% red saturation. Subjects
provided hourly saliva samples from 19:00:00 until habitual
bedtime. Habitual bedtime was defined for each subject as
their average bedtime recorded by the Actiwatch device over
the previous 7 nights. A small pastry was provided after the
20:00:00 sample. Eating was prohibited within 30 minutes
of sampling. Where habitual bedtime had not been reached
after the 23:00:00 sample, subjects were allowed to return
home but were requested to continue hourly sampling at
home in a similar dim environment until habitual bedtime.
Previous research has found that samples can be reliably
collected in the home environment.63,64 Samples collected
at home were prelabeled, immediately stored in the individ-
ual’s fridge, and returned to the primary researcher (SCF)
the following morning.
Visit 3
On waking the next day, subjects provided a saliva sample
prior to getting out of bed and turning room lights on.
Collection time was recorded. Subjects attended the labo-
ratory at 08:20:00 to return all saliva samples, and between
08:30:00 and 10:00:00, serum and final saliva samples were
collected in a seated position under uniform indoor photopic
illumination.
Sample Collection and Melatonin Analysis
Blood samples were collected from the antecubital vein.
Samples were centrifuged at 1800 g for 15 minutes at 4°C
within 1 hour of collection, and 1000 μL of serum was
isolated from the centrifuged sample. Saliva samples were
collected via the “passive drool” method with subjects in
a seated position. Subjects were asked to rinse their mouth
with water 10 minutes prior to saliva collection and to refrain
from using lip makeup during the sampling period. Subjects
were then instructed to tilt their head forward and let saliva
pool on the floor of their mouths before drooling the sample
through a SalivaBio Collection Aid (Salimetrics LLC, State
College, PA, USA) into a polypropylene vial. All samples
were stored at −80°C prior to analysis.
Melatonin quantitation in all biomatrices was conducted
by online solid-phase extraction (SPE) coupled with high-
performance liquid chromatography tandem mass spec-
trometry (HPLC-MS/MS). HPLC was a Shimadzu Nexera XR
(Kyoto, Japan), and separation was performed in gradient
mode. Mass spectrometer was an API 4000 triple quadrupole
(QQQ) (AB Sciex, Warrington, UK) equipped with a turbo
ion spray source. Melatonin powder, ≥98%, was purchased
from Sigma-Aldrich (Dorset, UK). Melatonin-d4 (internal
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TABLE 1. Demographics for All Subjects, Myopes, and Emmetropes [median (IQR)]
Characteristic All Subjects (n = 51) Myopes (n = 28) Emmetropes (n = 23) P Value
Sex, female/male, n 29/22 17/11 12/11
Age (y) 21.4 (20.1 to 24.0) 21.7 (20.2 to 23.4) 21.2 (20.0 to 24.4) 0.86
SER (DS)* −0.94 (−3.28 to +0.28) −3.18 (−4.26 to −1.78) 0.44 (−0.03 to +0.58) <0.0001†
Axial length (mm)* 24.24 (23.57 to 25.40) 25.32 (24.72 to 25.84) 23.57 (23.04 to 23.86) <0.0001†
Values are presented as median (interquartile range) unless otherwise indicated.
P value for two-tailed Mann-Whitney U test compares myopes to emmetropes.
*Indicates independent samples t-test comparing myopes to emmetropes.
† Indicates significance at P ≤ 0.05.
standard, ISTD), was purchased from Cambridge Bioscience
(Cambridge, UK). All other reagents were from Sigma-
Aldrich unless otherwise stated. Methods for all biomatrices
were developed and validated in accordance to The Interna-
tional Council for Harmonisation (ICH) of Technical Require-
ments for Pharmaceuticals for Human Use guidelines for
bioanalytical method validation (ICH M10, 2019) by the Mass
Spectrometry Centre at Ulster University (Appendix).
DLMO
The DLMOwas calculated dynamically using the “3k” thresh-
old method.52,65 Individual thresholds were calculated for
each subject as the mean plus two standard deviations of
three low daytime melatonin concentrations. A dynamic
threshold was chosen in light of previously identified refrac-
tive error–related variances in melatonin concentration.50
Published research reports that this dynamic method is
acceptable when using an hourly sampling protocol and
provides a better estimate of the point at which melatonin
levels begin to rise, compared with alternative methods
such as the low static threshold approach.66 DLMO was
defined for each subject as the time at which melatonin rose
above the “3k” threshold, determined by linear interpola-
tion between the points immediately above and below the
threshold.
Actiwatch Data Analysis
Actiwatch data were downloaded and analyzed using the
Philips Respironics software (Actiware 6.0.9). An automatic
software algorithm determined major rest intervals on each
actogram. Actograms were visually analyzed, and periods
where the device had been removed for 15 minutes or
more were excluded. This process removed 2.6% of data
in total across all participants. Actiware software summary
sleep statistics were generated and mean values extracted
and used in analysis.60,67–70 Raw light exposure and physi-
cal activity data were exported to an Excel file. To align with
previous myopia research,61,62 time spent “outdoors” was
defined as the time spent exposed to illuminations greater
than 1000 lux. Light exposure data were subsequently cate-
gorized to determine the daily time (in minutes) subjects
spent exposed to scotopic (≤0.01 lux), mesopic (0.01 to
≤3 lux), indoor photopic (3 to ≤1000 lux), and outdoor
photopic (>1000 lux) illumination. Furthermore, both the
mean time at which exposure to illuminations greater than
1000 lux (MLiT1000) occurred and the standard deviation of
MLiT1000 were calculated as described by Reid et al.71 This
allowed examination of relations between refractive error,
circadian phase or melatonin, and the timing and spread
of “outdoor” light exposure. Briefly, MLiT1000 was defined
as the average clock time of all light exposure data points
above 1000 lux. Physical activity data were categorized to
determine the time spent in sedentary (≤59 CPM), light (59
to ≤399 CPM), moderate (399 to ≤1404 CPM), and vigorous
(>1404 CPM) activity during active periods. Cutoff points for
physical activity categories were derived from a validation
study evaluating the Actiwatch-2 device in a similar young
adult cohort.72
Statistical Analysis
Statistical analyses were performed in SPSS (IBM SPSS Statis-
tics for Windows Version 25.0; SPSS, Chicago, IL). Data
were analyzed for normality using the Shapiro-Wilk test.
Parametric data were analyzed using independent sample
t-tests. Nonparametric data were analyzed using the Mann-
Whitney U test for independent samples. Spearman’s corre-
lation assessed the correlation between melatonin, SER,
axial length, objective light exposure, physical activity, and
sleep metrics. Pearson’s chi-square test assessed whether
PSQI or MEQ scores were associated with sex or the pres-
ence/absence of myopia. Multiple regression analysis eval-
uated the strength of association between significant vari-
ables and melatonin concentration. Results are presented
as median (interquartile range). In all instances, a P value
of ≤0.05 was considered statistically significant. Holm-
Bonferroni correction was applied to control for multiple
statistical testing of salivary melatonin across the sampling
period.73
RESULTS
Fifty-one subjects completed the protocol across 8 weeks.
Noncycloplegic spherical equivalent refraction did not differ
significantly between right and left eyes (P = 0.94). Only
right eye data are considered further. Table 1 summarizes
sex, age, and refractive and axial length data, and Table 2
summarizes subjective and objective measures of chrono-
type, sleep, activity, and light exposure data for all subjects
and by refractive group. Briefly, chronotype, sleep quality
and duration, and physical activity metrics did not differ
significantly between refractive groups. Neither refractive
group nor gender were significantly associated with higher
proportions of subjects categorized as having “good” or
“poor” PSQI sleep quality (χ2 = .35, P = 0.56 and χ2 =
.13, P = 0.72, respectively), and chronotype classification,
as determined by the MEQ, was not significantly associated
with refractive group (χ2 = 2.74, P = 0.26) or sex (χ2 = 3.12,
P = 0.21). Neither date nor daylength at time of assessment
differed significantly between refractive groups (P = 0.73
for both). As a group, myopes spent statistically more time
exposed to “indoor” photopic conditions compared with
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TABLE 3. Daily Time (Minutes) Spent in Different Intensities of Light Exposure (Scotopic, Mesopic, Indoor Photopic, and Outdoor Photopic)
and Physical Activity (Sedentary, Light, Moderate, and Vigorous Activity During Active Periods) for All Subjects, Myopes, and Emmetropes
Characteristic All Subjects (n = 51) Myopes (n = 28) Nonmyopes (n = 23) P Value
Light exposure
Scotopic (<0.01 lux) 556 (495–616) 564 (476-615) 547 (517–614) 0.65
Mesopic (0.01 to <3 lux) 200 (161–258) 185 (152–247) 242 (173–264) 0.23
Indoor photopic (3 to <1000 lux)* 633 (543–711) 649 (584–742) 606 (511–687) 0.05†
Outdoor photopic (≥1000 lux) 26 (16–43) 27 (19–44) 26 (14–41) 0.58
Physical activity
Sedentary activity (<59 CPM)* 315 (244–360) 321 (241–368) 317 (274–347) 0.85
Light activity (59 to <399 CPM)* 399 (342–430) 401 (344–429) 383 (347–439) 0.84
Moderate activity (399 to <1404 CPM) 247 (215–300) 248 (223–299) 228 (212–330) 0.91
Vigorous activity(≥1404 CPM) 16 (10–27) 16 (10–23) 15 (10–35) 0.33
Values are presented as median (interquartile range) unless otherwise indicated. P value for two-tailed Mann-Whitney U test compares
myopes to emmetropes.
* Indicates independent samples t-test comparing myopes to emmetropes.
† Indicates significance at P ≤ 0.05.
FIGURE 1. Median salivary melatonin concentration (pg/mL) at each collection time point for myopes (gray filled square) and emmetropes
(open circle). Error bars denote 95% confidence intervals.
their nonmyopic peers (P = 0.05, Table 3). However, the
amount of time individuals spent “indoors” was not signif-
icantly correlated to SER or axial length (Spearman’s rank,
ρ = –.17, P = 0.24 and ρ = .20, P = 0.16, respectively),
and no other light exposure parameter differed significantly
between groups (Tables 2 and 3). Of note, MLiT1000 tended
to be earlier for myopes compared with emmetropes, but
the difference between refractive error groups did not reach
statistical significance (P = 0.07), and MLiT1000 was not
significantly correlated to either SER or axial length (AL)
(Spearman’s rank, ρ = –.17, P = 0.23 and ρ = –.08, P =
0.58, respectively).
Melatonin Characteristics
At every time point sampled, serum and salivary melatonin
levels were significantly higher in the myopic group (Fig. 1
and Table 4, P ≤ 0.001 for all) and correlated to both SER
and axial length (Fig. 2 and Table 5). As indicated in Table 4,
eight saliva samples displayed a melatonin concentration
below the assay’s limit of detection (LOD) and were not
included in analysis. Sample collection time did not vary
significantly between refractive groups for any time point
(Mann-Whitney, P > 0.05 for all). Furthermore, daylength
at time of sampling was not significantly associated with
morning serum melatonin (Spearman’s rank, ρ = –.015,
P = 0.92).
Serum melatonin levels exhibited a weak positive corre-
lation with time spent in moderate activity (ρ = .29, R2 =
.07, P = 0.04) (Table 6). No other sleep, physical activity,
or light exposure metric was significantly associated with
serum melatonin concentration (Spearman’s rank, P > 0.05
for all). Less mesopic light exposure tended to be correlated
with higher levels of serum melatonin (ρ = –.27, R2 = .08, P
= 0.06), but this relationship did not reach statistical signifi-
cance. Multiple linear regression analysis evaluated the rela-
tive strength of association between morning serum mela-
tonin and refractive error (B = –.34, β = –.42, P = 0.001),
moderate activity (B = .009, β = .32, P = 0.01), and mesopic
light exposure (B = –.007, β = –.29, P = 0.02). All variables
contributed significantly to explaining the variance in serum
melatonin measures, F(3, 46) = 7.23, P < 0.001, R2 = 0.32,
R2adjusted = .28, and based on standardized coefficients (β),
refractive error was the strongest contributor.
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TABLE 4. Melatonin Concentration in Serum (pg/mL) and Saliva (pg/mL) Samples Collected at Different Time Points for All Subjects, Myopes,
and Emmetropes
Melatonin Concentration
Time Point All Subjects Myopes Emmetropes P Value
Serum
09:10:00 n = 51 n = 28 n = 23
(08:57:30–09:25:00) 4.46 (3.28–5.85) 5.43 (4.32–6.53) 3.45 (2.75–4.52) <0.001*,†
Saliva
08:00:00 n = 47 n = 28 n = 19 (+4 <LOD)
(07:27:30–08:06:15) 2.62 (1.46–3.62) 3.30 (2.37–4.34) 1.48 (0.86–2.53) 0.001*,†
09:10:00 n = 49 n = 28 n = 21 (+2 <LOD)
(09:00:00–09:20:00) 2.07 (1.59–3.69) 3.43 (1.96–3.94) 1.59 (1.37–2.03) 0.001*
19:00:00 n = 49 n = 28 n = 21 (+2 <LOD)
2.25 (1.56–3.80) 3.56 (2.37–4.09) 1.58 (1.23–1.95) <0.0001*
20:00:00 n = 51 n = 27 n = 23
2.97 (2.18–5.67) 5.18 (2.86–5.86) 2.41 (1.75–3.08) <0.0001*,†
21:00:00 n = 51 n = 28 n = 23
4.39 (3.53–7.33) 6.83 (4.24–7.98) 3.59 (2.5–4.3) <0.001*
22:00:00 n = 51 n = 28 n = 23
8.38 (6.51–15.01) 13.19 (7.73–17.00) 6.57 (5.65–8.16) <0.0001*
23:00:00 n = 51 n = 28 n = 23
19.11 (14.14–24.93) 24.11 (17.2–28.48) 14.88 (13.32–18.77) <0.0001*,†
n = 41 n = 23 n = 18
00:00:00 (00:00:00–00:00:00) 30.18 (27.13–35.54) 35.35 (30.71–37.44) 27.22 (24.16–29.13) <0.0001*
DLMO n = 48 n = 27 n = 21
20:22:46 (20:16:22–20:31:04) 20:22:49 (20:16:00–20:32:59) 20:22:43 (20:18:18–20:28:22) 0.98
Values are presented as median (interquartile range) unless otherwise indicated. P value for two-tailed Mann-Whitney U test compares
myopes to emmetropes. Holm-Bonferroni correction was applied to control for multiple statistical tests.
* Indicates independent samples t-test comparing myopes to emmetropes.
† Indicates significance at P ≤ 0.05.
FIGURE 2. Scatter graphs showing the correlation between morning serum (A, B) and salivary (C, D) melatonin, SER (top row), and axial
length (bottom row). ρ = Spearman’s correlation coefficient. *Significant at P ≤ 0.05.
Collection time for corresponding morning serum and
saliva samples did not vary significantly (Student’s t-test,
P > 0.05), and morning salivary melatonin levels were
significantly correlated to corresponding serum concentra-
tions of melatonin (P < 0.001) (Fig. 3).
DLMO-Derived Circadian Phase
DLMO was successfully determined for 48 subjects (27
myopes and 21 emmetropes); two emmetropes had daytime
melatonin levels below the LOD, and one myopic subject
provided only two “daytime” samples, which prevented the
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TABLE 5. Relationship Between Salivary Melatonin Concentration
at Different Sampling Times and Both SER and AL
SER AL
Sampling Time ρ R2 P ρ R2 P
08:00:00 −.41 .14 0.004* .39 .16 0.007*
09:10:00 −.43 .17 0.004* .49 .21 0.001*
19:00:00 −.51 .20 0.001* .57 .25 <0.001*
20:00:00 −.49 .19 0.002* .50 .22 0.001*
21:00:00 −.47 .18 0.002* .51 .23 0.001*
22:00:00 −.52 .18 0.001* .54 .22 <0.001*
23:00:00 −.48 .20 0.002* .47 .22 0.001*
00:00:00 −.54 .21 0.001* .53 .23 0.001*
ρ = Spearman’s correlation coefficient.
Holm-Bonferroni correction was applied to control for multiple
statistical tests.
* Indicates significance at P ≤ 0.05.
TABLE 6. Relationship Between Daily Time (Minutes) Spent in
Different Intensities of Both Light Exposure and Physical Activity,
and Morning Serum Melatonin Concentration (pg/mL)
Serum Melatonin
Characteristic ρ R2 P
Light exposure
Scotopic(<0.01 lux) .07 .02 0.61
Mesopic(0.01 to <3 lux) −.27 .08 0.06
Indoor photopic(3 to <1000 lux) .04 .003 0.80
Outdoor photopic(≥1000 lux) .10 .01 0.51
Physical activity
Sedentary activity(<59 CPM) −.22 .06 0.12
Light activity(59 to <399 CPM) −.20 .03 0.15
Moderate activity(399 to <1404 CPM) .29 .07 0.04*
Vigorous activity(≥1404 CPM) .26 .05 0.07
ρ = Spearman’s correlation coefficient.
* Indicates significance at P ≤ 0.05.
FIGURE 3. Scatter graph showing the correlation of salivary mela-
tonin with serum melatonin levels. ρ = Spearman’s correlation coef-
ficient. *Significant at P ≤ 0.05.
determination of DLMO. DLMO did not differ significantly
between refractive error groups (Table 4, P = 0.98) and was
not associated with SER or axial length (Spearman’s rank, ρ
= . 06, P = 0.71 and ρ = –.11, P = 0.45, respectively). Lower
levels of PSQI-reported sleep duration were significantly
associated with a later DLMO (Spearman’s rank, ρ = –.34,
P =.02). Otherwise, DLMO was not significantly associated
with any other self-reported questionnaire data or any objec-
tive sleep, light exposure, or physical activity metric (Spear-
man’s rank, P > 0.05 for all).
Age was not significantly correlated with serum mela-
tonin or DLMO (Spearman’s correlation, ρ = .028, P =
0.85 and ρ = –.106, P = 0.47, respectively), and neither
serum melatonin nor DLMO were significantly associated
with sex (Mann-Whitney, P = 0.68 and P = 0.67, respec-
tively). Twenty-three women provided information regard-
ing their menstrual phase. At the time of sampling, women
reported being in either the luteal (n = 15) or follicular
phase (n = 8) of their menstrual cycle. In this small group
of women, menstrual phase was not associated with serum
melatonin (independent samples t-test, t(21) = −1.31, P =
0.21) or DLMO (Mann-Whitney, P = 0.73).
DISCUSSION
In light of accumulating evidence implicating circadian
dysregulation as a factor in myopia development,23 the
present study explored circadian phase and melatonin
concentration in young adult myopes and emmetropes,
with consideration of prior light exposure, physical activ-
ity, and sleep. The outcomes confirm the report of Kear-
ney et al.50 that serum melatonin is significantly elevated in
adult myopes and, furthermore, illustrate that this associa-
tion and the correlation between melatonin, axial length, and
magnitude of myopia is demonstrable through the less inva-
sive method of saliva sampling. The elevation of melatonin
in samples obtained from myopic subjects was consistent
throughout the sampling period, and there was no difference
in circadian phase between refractive groups as assessed
by DLMO. The present cross-sectional investigation cannot
identify whether the association between higher melatonin
in myopes is a cause or consequence of myopia but indi-
cates that refractive error explains some of the individual
variability seen in melatonin profiles.74,75 Carefully designed
prospective studies are now required to better understand
the relationship between melatonin, circadian rhythms, and
refractive error.
The data presented here demonstrate that elevated
systemic melatonin levels are associated with increasing
levels of myopia, a greater amount of time spent under-
taking moderate physical activity, and less time exposed
to mesopic illumination (0.01 to ≤3 lux). Together, these
variables explain 32% of the individual variability in morn-
ing serum melatonin, with refractive error the most potent
contributor to the model. Both physical activity and light
exposure provide temporal cues to our circadian system and
are known to influence melatonin secretion.76 The outcomes
of the present study offer further support for a contributing
role of circadian physiology to ocular growth control mecha-
nisms, but the exact nature of this role cannot be determined
from the present investigation.
Our results are in contrast with those reported by two
studies from the Ostrin laboratory evaluating refractive error
and melatonin.37,68 In neither study was a significant differ-
ence in melatonin concentration found between refractive
groups. Abbott et al.68 collected a single morning saliva
sample between 09:00:00 and 11:00:00 and found no signifi-
cant difference in melatonin concentration between myopes
and emmetropes. Burfield et al.37 collected saliva samples
every 4 hours for 24 hours to assess the diurnal variation in
melatonin. Burfield et al.37 reported no significant difference
in the diurnal amplitude, acrophase (peak), or mean concen-
tration of melatonin between myopes and emmetropes. The
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disparity in outcomes between the present study and those
reported by Ostrin’s group may reflect differences in mela-
tonin quantification methodology, participant demograph-
ics, and/or geographical location. Of particular note, both
studies from the Ostrin laboratory analyzed saliva samples
for melatonin concentration using a commercial enzyme-
linked immunosorbent assay (ELISA) kit. Compared with the
highly specific liquid chromatography/mass spectrometry
(LC/MS) methods used in the present study, the ELISA tech-
nique is typically limited by lower specificity for the target
compound. As such, cross-reactivity of compounds with a
similar molecular structure to melatonin during ELISA anal-
ysis may have masked interrefractive group differences in
previous work.
Patterns of light exposure identified within the refrac-
tive groups in the present study are consistent with previ-
ous reports evaluating light exposure profiles and refrac-
tive error in adulthood, which fail to identify a relation-
ship between recent light exposure history and SER or AL.77
While at the group level, myopes spent on average signifi-
cantly more time exposed to “indoor” levels of illumination
compared with emmetropes, recent light exposure history
in relation to scotopic, mesopic, or “outdoor” light levels
did not differ by group in these adult subjects. This find-
ing contrasts with published data from children. Myopic
children have been shown to spend significantly less time
outdoors (>1000 lux) and more time in mesopic illumina-
tion (1–30 lux) compared with their nonmyopic peers.61,62
A significant association has also been reported between
greater average daily light exposure and less axial elonga-
tion in both children and young adults.78,79 Childhood data
gathered during a period of dynamic eye growth may better
inform our understanding of the environmental factors that
promote myopia onset and progression, compared with
adult data taken when ocular growth and myopia progres-
sion are less active.
Other factors that may have restricted the present study’s
ability to expose relationships between previous light expo-
sure history, melatonin, and refractive measures are the
time of year and geographical location at which data were
collected. Chronobiology research has shown that brighter
daytime light exposure, which is typically accompanied by
longer photoperiods and a shortening of the melatonin
secretion phase, is associated with acute elevation in the
amplitude of nocturnal melatonin secretion.80–82 Such find-
ings have been observed experimentally and seasonally.80–83
By contrast, in the present study, there were no signifi-
cant differences in total, average, or maximum light expo-
sure between myopes and emmetropes that could explain
the differences seen in melatonin concentration. Neither
scotopic, “indoor,” or “outdoor” light exposure metrics (at
wrist level) nor the timing or spread of “outdoor” light expo-
sure (MLiT1000) were significantly associated with melatonin
levels. Light exposure profiles were evaluated at the end
of winter in Northern Ireland (latitude of 55°N). Irrespec-
tive of refractive error, subjects spent an average of only 26
(interquartile range, 16–43) minutes per day exposed to illu-
minations >1000 lux. The low frequency of outdoor light
exposure may have also limited opportunity for exploring
associations between both the timing and spread of outdoor
light exposure (MLiT1000) and refractive error, circadian
phase, and melatonin. Differences in light exposure profiles
between refractive groups may be better evaluated during
summer months when individuals are less constrained by
weather and daylength. Light exposure profiles may also be
better represented by measuring light exposure at eye level,
rather than at the wrist, now possible with advances in tech-
nology.84
Reduced subjective sleep quality and quantity, both
outputs of the circadian system, have been reported in
myopic children.85,86 These associations have not been
consistently demonstrated in studies evaluating sleep and
refractive error in adults, either using subjective (ques-
tionnaire) or objective (actigraphy) methods of profil-
ing sleep.68,86 The present study found no association
between objective or subjective sleep metrics and refractive
error. This is not surprising. In addition to questionnaire-
associated recall bias, an inherent limitation of both ques-
tionnaire and actigraph data is that they primarily reflect
sleep-wake cycles, which are heavily influenced by social
factors, rather than internal circadian time.
The present study benefits from adherence to a strict
sample collection protocol with comprehensive exclusion
criteria and a highly specific LC/MS analysis technique.
There were no significant differences in sample collection
times between myopes and emmetropes or between corre-
sponding morning saliva and serum samples. Melatonin
concentration is known to increase when moving from a
supine to a standing position and vice versa; therefore, all
human tissue samples were collected in a seated position.
A dim uniform lighting environment was maintained during
the DLMO protocol. While subjects were permitted to use
screens, these were all set to the lowest screen intensity and
100% red saturation. The amount of time each individual
subject spent using screens was not recorded during the
DLMO protocol. Recently published research demonstrates
that the circadian system is highly sensitive to low evening
light exposures and that there is significant interindivid-
ual variability in relation to this stimulus.75 As such, future
research should consider the use of short-wavelength block-
ing goggles and prohibiting screen use to further control
environmental lighting impacts during DLMO phase assess-
ments.
In conclusion, these findings demonstrate for the first
time that adult myopia is associated with significantly
elevated levels of circulating melatonin in both morning and
evening samples but that circadian phase, as indicated by
DLMO, does not differ between myopes and emmetropes.
This study also establishes that associations between mela-
tonin and refractive error are detectable through noninva-
sive saliva sampling. Accumulating research from animal
models implies that disrupted circadian rhythms contribute
to myopia development, but there are few data from human
subjects to corroborate this proposition. The present study
presents robust evidence that circulating levels of mela-
tonin, a key circadian hormone, are significantly different
in adult myopes compared with their emmetropic peers.
The significant association found between refractive error
and melatonin cannot be explained by differences in circa-
dian phase, recent light exposure history, physical activity,
or sleep.Well-designed prospective studies are now required
to ascertain the relevance of these findings to the onset and
development of myopia, particularly whether elevated mela-
tonin levels are evident before and during myopia develop-
ment. Accruing such knowledge may provide insight into
the factors promoting childhood myopia and how increased
time spent outdoors helps to regulate homeostatic eye
growth.
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APPENDIX
Chromatographic Conditions
StrataX online SPE (25 μm 20, 20 mm) column
was purchased from Phenomenex (Macclesfield,
Cheshire, UK). SPE mobile phase (A) was 20 mM
ammonium acetate/methanol (95:5, v/v). Analyt-
ical column Kinetex reverse phase C18 3.0 ×
150 mm; 3 μm was purchased from Phenomenex
(Macclesfield, UK). Flow rate was set at 0.3 mL/min
(constant), column temperature was set at 35°C,
and injection volume was 10 μL. Sample diluent
was 0.1% ascorbic acid with 0.001% ETDA in 90:10
(methanol/water, v/v). Mobile phases were (B)
90:10 (v/v) (10 mM ammonium formate adjusted
to pH 3.0 with formic acid/methanol) and (C)
methanol.
Gradient Profile.






Mass Spectrometer Conditions. Analysis was
carried out in positive ion mode using multiple
reaction monitoring (MRM) mode. Online tuning
was performed to maximize parent isolation and
daughter generation. Ionization and fragmentation
conditions were set as follows: CAD (Arb): 6, CUR
(Arb): 40, GSI (Arb): 35; GSII (Arb) 40; IS: (V) 5500;
temp (°C): 500.
MRM Transitions
Parent Quantifier Qualifier CE DP CXP EP
Compound (m/z) (m/z) (m/z) (V) (V) (V) (V)
Melatonin 233.1 174.2 159.0 23/49 96 10/12 10
ISTD 237.1 178.1 NA 23 96 10 10
Sample Preparation and HPLC/MS/MS Analysis.
Saliva. Accurately pipette 200 μL of saliva into a
1.5-mL Eppendorf tube, add 200 μL of water and
25 μL of the internal standard working solution (1
ng/mL), and mix well. Then, add 450 μL precipita-
tion reagent (cold acetonitrile), mix with vortex (1
minute, full speed), and centrifuge for 10 minutes
at 13,000 rpm at room temperature. Then transfer
250 μL of the supernatant to an HPLC insert and
then into a 1.5-mL HPLC vial and store at −20°C
until analysis. The limit of quantitation (LOQ) was
1.0 pg mL−1, the LOD was 0.2 pg mL−1, the dynamic
range was 1.0–100 pg mL−1 (R2 of nominal versus
calculated was 0.997 with no intercept bias). The
accuracy at low Quality control (QC) (5 pg mL−1)
and high QC (25 pg mL−1) were within 85% to 115%
precision (low QC [n = 6, coefficient of variation
(CV) = 4.1%], high QC [n = 6, CV = 2.9%]). Results
are an average of n = 2 preparation.
Serum. Serum melatonin was quantified using
liquid chromatography followed by online solid-
phase extraction and tandem mass spectrome-
try analysis (LC-online SPE-MS/MS) as previously
described by Kearney et al.50 In brief, accurately
pipette 400 μL of serum into a 1.5-mL Eppendorf
tube; add 25 μL of the internal standard working
solution (1 ng/mL), 50 μL of serum media solution,
and 700 μL of precipitation reagent (cold acetoni-
trile) mix with vortex (1 minute, full speed); and
centrifuge for 10 minutes at 13,000 rpm. Then trans-
fer 800 μL of the supernatant to a 1.5-mL amber
HPLC vial and store at −20°C until analysis. The
LOQ was 2.5 pg mL−1, the LOD was 1.0 pg mL−1,
and the dynamic range was 2.5–200 pg mL−1 (R2 of
nominal versus calculated was 0.992 with no inter-
cept bias). The accuracy at low QC (25 pg mL−1)
and high QC (100 pg mL−1) were within 85% to
115% precision (low QC [n = 6, CV = 3.7%], high
QC [n = 6, CV = 4.2%]). Results are average of n =
2 preparation.
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